Compound Evidence File
#EC-2026-0679
Supertest 450
Filed under Injectable Oils. The bureau holds 98 laboratory returns for this compound from 36 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
36 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 10.0 | 10.0 | 27 Jan 2026 | 19 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Mar 2026 | 19 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 10.0 | 10.0 | 21 Mar 2026 | 13 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 4 May 2026 | 21 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 | 28 Mar 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 | 2 Apr 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Feb 2026 | 4 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 9.9 | 15 Nov 2025 | 21 May 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 10.0 | 9 Apr 2026 | 9 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 3 May 2026 | 5 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 9.9 | 24 Jun 2026 | 11 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Feb 2026 | 21 Feb 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 12 Dec 2025 | 15 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 6 Jan 2026 | 26 Mar 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 1 Jun 2026 |
| Peptide SciencesCASE #VI-2026-0867 | X | 1 | 9.8 | 9.8 | 9.8 | 6 May 2025 | 6 May 2025 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 9.3 | 9.3 | 9.3 | 2 Apr 2025 | 2 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.9 | 6.2 | 9.9 | 24 May 2026 | 24 May 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 8.5 | 8.5 | 8.5 | 9 Jun 2025 | 9 Jun 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 8.4 | 8.4 | 8.4 | 7 May 2025 | 7 May 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.2 | 7.0 | 8.9 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.2 | 6.8 | 9.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.1 | 7.4 | 8.6 | 24 May 2026 | 24 May 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 8.1 | 8.1 | 8.1 | 8 Jul 2025 | 8 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 8.0 | 7.1 | 8.8 | 25 May 2026 | 25 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 7.8 | 7.8 | 7.8 | 6 May 2025 | 6 May 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 6 | 7.5 | 4.9 | 9.7 | 14 Jan 2025 | 17 May 2026 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 | 16 Mar 2025 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 3 | 7.0 | 6.2 | 7.6 | 28 Mar 2025 | 20 May 2026 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 | 6 May 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 5.8 | 5.8 | 5.8 | 6 May 2025 | 6 May 2025 |
| TydesCASE #VI-2026-0493 | X | 3 | 4.5 | 2.8 | 5.9 | 8 Jul 2025 | 21 May 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 2.5 | 2.5 | 2.5 | 3 Jul 2025 | 3 Jul 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
Open any subject to view the batch-level evidence for Supertest 450 alone.